Suzhou Boyuan Pharmaceutical

Suzhou Boyuan Pharmaceutical is a specialized pharmaceutical enterprise focused on the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. Headquartered in the Suzhou Industrial Park, the company has established a robust portfolio in the central nervous system, cardiovascular, and anti-inflammatory therapeutic sectors. Its core products include widely used small molecules such as Gabapentin, Pregabalin, and Celecoxib, which are supplied to both domestic and international markets. Suzhou Boyuan operates high-standard GMP manufacturing facilities and offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company is recognized for its technical expertise in complex chemical synthesis and its commitment to quality standards in the pharmaceutical supply chain.